Skip to main content
logo
Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
8.94
+0.15 (1.71%)
Mar 16, 2026, 10:51 AM EDT - Market open

Embecta Revenue

Embecta had revenue of $261.20M in the quarter ending December 31, 2025, a decrease of -0.27%. This brings the company's revenue in the last twelve months to $1.08B, down -2.53% year-over-year. In the fiscal year ending September 30, 2025, Embecta had annual revenue of $1.08B, down -3.80%.

Revenue (ttm)
$1.08B
Revenue Growth
-2.53%
P/S Ratio
0.49
Revenue / Employee
$583,622
Employees
1,850
Market Cap
529.43M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 20251.08B-42.70M-3.80%
Sep 30, 20241.12B2.30M0.21%
Sep 30, 20231.12B-8.70M-0.77%
Sep 30, 20221.13B-35.80M-3.07%
Sep 30, 20211.17B79.80M7.35%
Sep 30, 20201.09B-23.50M-2.12%
Sep 30, 20191.11B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Azenta595.03M
AngioDynamics307.31M
STAAR Surgical Company239.44M
OraSure Technologies115.02M
BioLife Solutions96.21M
Kestra Medical Technologies74.26M
KORU Medical Systems41.13M
Utah Medical Products38.52M
Revenue Rankings

EMBC News

More News